These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32061715)

  • 1. Tauroursodeoxycholic acid attenuates cisplatin-induced hearing loss in rats.
    Lee CH; Park SS; Lee DH; Lee SM; Kim MY; Choi BY; Kim SY
    Neurosci Lett; 2020 Mar; 722():134838. PubMed ID: 32061715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Otoprotective Effects of Zingerone on Cisplatin-Induced Ototoxicity.
    Lee CH; Lee DH; Lee SM; Kim ASY
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-Dependent Effects of Resveratrol on Cisplatin-Induced Hearing Loss.
    Lee CH; Kim KW; Lee SM; Kim SY
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tauroursodeoxycholic acid attenuates cisplatin-induced ototoxicity by inhibiting the accumulation and aggregation of unfolded or misfolded proteins in the endoplasmic reticulum.
    Wen Y; Zong S; Liu T; Du P; Li H; Xiao H
    Toxicology; 2021 Apr; 453():152736. PubMed ID: 33631298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoplasmic Reticulum Stress Is Involved in Cochlear Cell Apoptosis in a Cisplatin-Induced Ototoxicity Rat Model.
    Zong S; Liu T; Wan F; Chen P; Luo P; Xiao H
    Audiol Neurootol; 2017; 22(3):160-168. PubMed ID: 29049998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tauroursodeoxycholic acid prevents hearing loss and hair cell death in Cdh23(erl/erl) mice.
    Hu J; Xu M; Yuan J; Li B; Entenman S; Yu H; Zheng QY
    Neuroscience; 2016 Mar; 316():311-20. PubMed ID: 26748055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AAV-mediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity.
    Cooper LB; Chan DK; Roediger FC; Shaffer BR; Fraser JF; Musatov S; Selesnick SH; Kaplitt MG
    Otol Neurotol; 2006 Jun; 27(4):484-90. PubMed ID: 16791039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of D-methionine on cochlear oxidative state with and without cisplatin administration: mechanisms of otoprotection.
    Campbell KC; Meech RP; Rybak LP; Hughes LF
    J Am Acad Audiol; 2003 Apr; 14(3):144-56. PubMed ID: 12859139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of HSP60 expression in the postnatal rat cochlea and rats with drug-induced hearing loss.
    Tian K; Song Y; Zhou K; Yue B; Qiu Y; Sun F; Wang R; Zha D; Qiu J
    Cell Stress Chaperones; 2018 Nov; 23(6):1311-1317. PubMed ID: 30196524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tauroursodeoxycholic acid attenuates gentamicin-induced cochlear hair cell death in vitro.
    Jia Z; He Q; Shan C; Li F
    Toxicol Lett; 2018 Sep; 294():20-26. PubMed ID: 29751043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allicin protects auditory hair cells and spiral ganglion neurons from cisplatin - Induced apoptosis.
    Wu X; Li X; Song Y; Li H; Bai X; Liu W; Han Y; Xu L; Li J; Zhang D; Wang H; Fan Z
    Neuropharmacology; 2017 Apr; 116():429-440. PubMed ID: 28062185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transtympanic administration of short interfering (si)RNA for the NOX3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat.
    Mukherjea D; Jajoo S; Kaur T; Sheehan KE; Ramkumar V; Rybak LP
    Antioxid Redox Signal; 2010 Sep; 13(5):589-98. PubMed ID: 20214492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lovastatin protects against cisplatin-induced hearing loss in mice.
    Fernandez K; Spielbauer KK; Rusheen A; Wang L; Baker TG; Eyles S; Cunningham LL
    Hear Res; 2020 Apr; 389():107905. PubMed ID: 32062294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levosimendan ameliorates cisplatin-induced ototoxicity: Rat model.
    Gozeler MS; Ekinci Akdemir FN; Yildirim S; Sahin A; Eser G; Askin S
    Int J Pediatr Otorhinolaryngol; 2019 Jul; 122():70-75. PubMed ID: 30978472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related hearing loss patterns in Fischer 344/NHsd rats with cisplatin-induced hearing loss.
    Bielefeld EC
    Hear Res; 2013 Dec; 306():46-53. PubMed ID: 24055622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Src-protein tyrosine kinase inhibitor to reduce cisplatin ototoxicity while preserving its antitumor effect.
    Bielefeld EC; Tanaka C; Chen GD; Coling D; Li M; Henderson D; Fetoni AR
    Anticancer Drugs; 2013 Jan; 24(1):43-51. PubMed ID: 22828384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Folic Acid on Cisplatin-Induced Ototoxicity: A Functional and Morphological Study.
    Tanyeli TT; Karadaş H; Akyıldız İ; Gökdoğan O; Sönmez Ç; Çavuş ME; Kaptan Z; Uzunkulaoğlu H; Arslan N; Zeybek ND
    J Int Adv Otol; 2019 Aug; 15(2):237-246. PubMed ID: 31347504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral Administration of Clinical Stage Drug Candidate SENS-401 Effectively Reduces Cisplatin-induced Hearing Loss in Rats.
    Petremann M; Tran Van Ba C; Broussy A; Romanet C; Dyhrfjeld-Johnsen J
    Otol Neurotol; 2017 Oct; 38(9):1355-1361. PubMed ID: 28796092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting nitrative stress for attenuating cisplatin-induced downregulation of cochlear LIM domain only 4 and ototoxicity.
    Jamesdaniel S; Rathinam R; Neumann WL
    Redox Biol; 2016 Dec; 10():257-265. PubMed ID: 27821327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulforaphane attenuates cisplatin-induced hearing loss by inhibiting histone deacetylase expression.
    Wang J; Tian KY; Fang Y; Chang HM; Han YN; Chen FQ
    Int J Immunopathol Pharmacol; 2021; 35():20587384211034086. PubMed ID: 34344210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.